Polymorphic analysis of a pharmaceutical preparation by NIR spectroscopy

被引:25
作者
Blanco, M [1 ]
Villar, A [1 ]
机构
[1] Univ Autonoma Barcelona, Fac Ciencies, Dept Quim, Unitat Quim Analit, E-08193 Barcelona, Spain
关键词
D O I
10.1039/b005746k
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A method for the characterization and determination of the crystalline form present in the amorphous miokamycin of a pharmaceutical preparation using near-infrared spectroscopy (NIRS) is proposed. The study leading to the development of the proposed method involved both qualitative (classification by residual variance analysis) and quantitative aspects (the determination of both total miokamycin and its crystalline form using multivariate calibration). Samples containing less than 5% of the total amount of miokamycin in its crystalline form can be accurately classified. Partial least-squares regression (PLSR) allows low contents of the crystalline form to be determined with absolute errors less than 1.5%, which is comparable to the limit of detection of the X-ray diffraction technique used as reference. Also, the total miokamycin content is determined by NIRS with errors less than 1%. The simplicity, expeditiousness and robustness of the proposed method make it an effective tool for determining both total and crystalline miokamycin in solid dosage forms.
引用
收藏
页码:2311 / 2314
页数:4
相关论文
共 22 条
[1]   Near-IR detection of polymorphism and process-related substances [J].
Aldridge, PK ;
Evans, CL ;
Ward, HW ;
Colgan, ST ;
Boyer, N ;
Gemperline, PJ .
ANALYTICAL CHEMISTRY, 1996, 68 (06) :997-1002
[2]   Development and validation of methods for the determination of miokamycin in various pharmaceutical preparations by use of near infrared reflectance spectroscopy [J].
Blanco, M ;
Coello, J ;
Eustaquio, A ;
Itturriaga, H ;
Maspoch, S .
ANALYST, 1999, 124 (07) :1089-1092
[3]   Near-infrared spectroscopy in the pharmaceutical industry [J].
Blanco, M ;
Coello, J ;
Iturriaga, H ;
Maspoch, S ;
de la Pezuela, C .
ANALYST, 1998, 123 (08) :135R-150R
[4]   Determination of polymorphic purity by near infrared spectrometry [J].
Blanco, M ;
Coello, J ;
Iturriaga, H ;
Maspoch, S ;
Pérez-Maseda, C .
ANALYTICA CHIMICA ACTA, 2000, 407 (1-2) :247-254
[5]  
BRITAIN HG, 1999, POLYMORPHISM PHARM S
[6]   The use of near infra-red spectroscopy to detect changes in the form of amorphous and crystalline lactose [J].
Buckton, G ;
Yonemochi, E ;
Hammond, J ;
Moffat, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 168 (02) :231-241
[7]   USES OF NEAR-INFRARED SPECTROSCOPY IN PHARMACEUTICAL ANALYSIS [J].
CIURCZAK, EW .
APPLIED SPECTROSCOPY REVIEWS, 1987, 23 (1-2) :147-163
[8]   DETERMINATION OF ALPHA-IMPURITIES IN THE BETA-POLYMORPH OF INOSINE USING INFRARED-SPECTROSCOPY AND X-RAY-POWDER DIFFRACTION [J].
DOFF, DH ;
BROWNEN, FL ;
CORRIGAN, OI .
ANALYST, 1986, 111 (02) :179-182
[9]   A COMPARATIVE SPECTROSCOPIC INVESTIGATION OF 2 POLYMORPHS OF 4'-METHYL-2'-NITROACETANILIDE USING SOLID-STATE INFRARED AND HIGH-RESOLUTION SOLID-STATE NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY [J].
FLETTON, RA ;
LANCASTER, RW ;
HARRIS, RK ;
KENWRIGHT, AM ;
PACKER, KJ ;
WATERS, DN ;
YEADON, A .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1986, (11) :1705-1709
[10]  
*FOSS NIRS, 1998, VIS VER 1 0 US MAN